Market Fallers: GlaxoSmithKline plc, Bunzl plc & Kingfisher plc

GlaxoSmithKline plc

Shares of GlaxoSmithKline plc ticker lookup code: LON:GSK has decreased -2.13% or -34.6 points throughout the session so far. Investors were far from a positive bunch while the stock has been in play. Range high for the period has seen 1648.8 and hitting a low of 1575. Volume total for shares traded at this point reached 5,007,607 with the daily average number around 10,575,440. A 52 week share price high is 1648.8 amounting to 27.2 points difference from the previous days close and the 52 week low at 1179.39 a difference of some 442.21 points. Market capitalisation is now £78,318.44m at the time of this report. The currency for this stock is Great British pence.Market cap is measured in GBP. This article was written with the last trade for GlaxoSmithKline plc being recorded at Monday, December 3, 2018 at 12:14:50 PM GMT with the stock price trading at 1587 GBX.

 

Shares of Bunzl plc with company EPIC: LON:BNZL has declined -1.45% or -35 points throughout today’s trading session so far. Sellers aired on the negative side throughout the trading session. The periods high has reached 2442 meanwhile the session low reached 2375. The volume total for shares traded up to this point was 346,926 whilst the average number of shares exchanged is 1,187,378. A 52 week high for the stock is 2466.5 amounting to 50.5 points different to the previous business close and a 52 week low sitting at 1918.5 making a difference of 497.5 points. Market capitalisation for the company is £8,100.05m at the time of this report. The currency for this stock is Great British pence.Market cap is measured in GBP. This article was written with the last trade for Bunzl plc being recorded at Monday, December 3, 2018 at 12:14:42 PM GMT with the stock price trading at 2381 GBX.

 

The trading price for Kingfisher plc with ticker code: LON:KGF has slid -1.84% or -4.6 points throughout the session so far. Sellers have not remained optimistic during the session. The high for the period has reached 255.3 dropping as low as 245.3. The volume total for shares traded up to this point was 2,899,147 with the daily average number around 9,672,452. The 52 week high price for the shares is 366 amounting to 116 points in difference on the previous days close and a 52 week low being 228.7 which is a variance of 21.3 points. This puts the market cap at £5,200.81m at the time of this report. The stock is traded in GBX. Mcap is measured in GBP. This article was written with the last trade for Kingfisher plc being recorded at Monday, December 3, 2018 at 12:14:45 PM GMT with the stock price trading at 245.4 GBX.

Share on:
Find more news, interviews, share price & company profile here for:
    GSK's Jemperli plus chemotherapy gains EU approval for broader use in first-line treatment of advanced or recurrent endometrial cancer, improving survival rates.
    GSK's Shingrix aims for FDA-approved prefilled syringe to simplify shingles vaccination, enhancing convenience for healthcare providers.
    GSK's ADC GSK5764227 gains FDA Breakthrough Therapy status for treating relapsed or refractory osteosarcoma, addressing critical unmet medical needs.
    Kingfisher plc announces the appointment of Ian McLeod as Non-Executive Director, while Catherine Bradley steps down after four years of dedicated service.
    GSK's Nucala has been approved in China as an add-on treatment for CRSwNP, marking the first anti-IL-5 therapy for adults with this chronic condition.

      Search

      Search